Persistent Burden of Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Among People With Type 1 Diabetes Despite Technology Use: A Follow-up Survey

Although most participants used CGM and the use of AID increased, approximately one-third of respondents did not achieve HbA1c targets, ∼20% continued to have SHEs in the last year, and ∼30% had IAH. This highlights that while CGM and AID systems are a significant advancement, their use alone has not mitigated the risk of severe hypoglycemia, and glucose management still remains suboptimal.

Authors

Institutions

Publication Details

Journal
Diabetes Care
Published
2026-02-26
DOI
https://doi.org/10.2337/dc25-2345
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Persistent Burden of Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Among People With Type 1 Diabetes Despite Technology Use: A Follow-up Survey

Megan E. Peter, TATHABBAI PAKALAPATI, EMILEE M. CORNELIUS, Jeremy H. Pettus et al.
Diabetes Care
Diabetes Management and Research
article

Persistent Burden of Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Among People With Type 1 Diabetes Despite Technology Use: A Follow-up Survey

Megan E. Peter, TATHABBAI PAKALAPATI, EMILEE M. CORNELIUS, Jeremy H. Pettus, Jordan S. Sherwood, Jennifer L. Sherr
article en

Abstract

Although most participants used CGM and the use of AID increased, approximately one-third of respondents did not achieve HbA1c targets, ∼20% continued to have SHEs in the last year, and ∼30% had IAH. This highlights that while CGM and AID systems are a significant advancement, their use alone has not mitigated the risk of severe hypoglycemia, and glucose management still remains suboptimal.

Diabetes CareVol. 49(4)
Yale University (US), University of California San Diego (US), T1D Exchange (US), Vertex Pharmaceuticals (United States) (US)
Leona M. and Harry B. Helmsley Charitable Trust, Vertex Pharmaceuticals, Insulet Corporation, Dexcom, National Institutes of Health, Moonshot Research and Development Program
Openalex Percentile: Top 43%
Diabetes Management and Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.